Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP (Q28210514)

Europe PubMed Central

PubMed ID

14563541

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563541

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0376-8716(03)00172-8

22 March 2024

author name string

Manuel Tancer

1

0 references

Chris-Ellyn Johanson

full work available at URL

2

0 references

language of work or name

English

0 references

publication date

24 October 2003

0 references

https://api.elsevier.com/content/article/PII:S0376871603001728?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0376-8716(03)00172-8

https://api.elsevier.com/content/article/PII:S0376871603001728?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0376-8716(03)00172-8

Drug and Alcohol Dependence

22 March 2024

published in

0 references

volume

72

0 references

issue

1

0 references

page(s)

33-44

0 references

cites work

Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Evaluation of Phentermine and Fenfluramine, Alone and in Combination, in Normal, Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Principles of initial experimental drug abuse liability assessment in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Drug preference and mood in humans: d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Gender differences in the subjective effects of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Specific neurotoxicity of chronic use of ecstasy

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

An exploration of the history and controversies surrounding MDMA and MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Ecstasy: dangers and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Abuse liability assessment of sibutramine, a novel weight control agent

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Increasing MDMA use among college students: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

The subjective effects of MDMA and mCPP in moderate MDMA users

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

'Is MDMA a human neurotoxin?': diverse views from the discussants

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900172-8

7 January 2021

Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers

23

1 reference

https://api.crossref.org/works/10.1016/S0376-8716(03)00172-8

Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction

22 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0376-8716(03)00172-8

22 March 2024

Identifiers